Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse

Abstract

Telomerase is a ribonucleoprotein enzyme that adds hexanucleotide repeats TTAGGG to the ends of chromosomes. Telomerase activation is known to play a crucial role in cell-immortalization and carcinogenesis. Telomerase is shown to have a correlation with cell cycle progression, which is controlled by the regulation of cyclins, cyclin dependent kinases (cdks) and cyclin dependent kinase inhibitors (cdkis). Abnormal expression of these regulatory molecules may cause alterations in cell cycle with uncontrolled cell growth, a universal feature of neoplasia. Skin cancer is the most prevalent form of cancer in humans and the solar UV radiation is its major cause. Here, we investigated modulation in telomerase activity and protein expression of cell cycle regulatory molecules during the development of UVB-induced tumors in SKH-1 hairless mice. The mice were exposed to 180 mjoules/cm2 UVB radiation, thrice weekly for 24 weeks. The animals were sacrificed at 4 week intervals and the studies were performed in epidermis. Telomerase activity was barely detectable in the epidermis of non-irradiated mouse. UVB exposure resulted in a progressive increase in telomerase activity starting from the 4th week of exposure. The increased telomerase activity either persisted or further increased with the increased exposure. In papillomas and carcinomas the enzyme activity was comparable and was 45-fold higher than in the epidermis of control mice. Western blot analysis showed an upregulation in the protein expression of cyclin D1 and cyclin E and their regulatory subunits cdk4 and cdk2 during the course of UVB exposure and in papillomas and carcinomas. The protein expression of cdk6 and ckis viz. p16/Ink4A, p21/Waf1 and p27/Kip1 did not show any significant change in UVB exposed skin, but significant upregulation was observed both in papillomas and carcinomas. The results suggest that telomerase activation may be involved in UVB-induced tumorigenesis in mouse skin and that increased telomerase activity may be associated with G1 phase of the cell cycle.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Balasubramanian S, Ahmad N, Jeedigunta S and Mukhtar H. . 1998 Biochem. Biophys. Res. Commun. 243: 744–748.

  • Bednarek A, Budunova I, Slaga TJ and Aldaz CM. . 1995 Cancer Res. 55: 4566–4569.

  • Bednarek A, Chu Y, Slaga TJ and Aldaz CM. . 1997 Mol. Carcinog. 20: 329–331.

  • Bianchi AB, Fischer SM, Robles AI, Rinchik EM and Conti CJ. . 1993 Oncogene 8: 1127–1133.

  • Blasco MA, Rizen M, Grieder CW and Hanahan D. . 1996 Nature Genet. 12: 200–204.

  • Broccoli D, Young JW and de Lange T. . 1995 Proc. Natl. Acad. Sci. USA 92: 9082–9086.

  • Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA and Sutherland RL. . 1993 Oncogene 8: 2127–2133.

  • Chadeneau C, Siegel P, Harley CB, Muller WJ and Bacchetti S. . 1995 Oncogene 11: 893–898.

  • Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Creider CW, Harley CB and Bacchetti S. . 1992 EMBO J. 11: 1921–1929.

  • Das M, Mukhtar H, Bik DP and Bickers DR. . 1987 Cancer Res. 47: 760–766.

  • Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W and Moore MAS. . 1997 Proc. Natl. Acad. Sci. USA 90: 182–193.

  • Greider CW. . 1991 Cell 67: 645–647.

  • Greider CW and Blackburn EH. . 1985 Cell 43: 405–413.

  • Hannon GJ and Beach D. . 1994 Nature 371: 257–261.

  • Holt SE, Aisner DL, Shay JW and Wright WE. . 1997 Proc. Natl. Acad. Sci. USA 94: 10687–10692.

  • Hunter T and Pines J. . 1994 Cell 79: 573–582.

  • Katiyar SK, Korman NJ, Mukhtar H and Agarwal R. . 1997 J. Natl. Cancer Inst. 89: 556–566.

  • Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilczynski S, Lee YY, Bartram CR and Koeffler HP. . 1995 Cancer Res. 55: 2266–2269.

  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW. . 1994 Science 269: 2011–2015.

  • Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J and Roos G. . 1997 Cancer Res. 57: 549–554.

  • Leach FS, Ellwdge SJ, Sherr CJ, Willson JKV, Markovitz S, Kinzler KW and Vogelstein B. . 1993 Cancer Res. 53: 1986–1989.

  • Li R, Waga S, Hannon GJ, Beach D and Stillman B. . 1994 Nature 371: 534–537.

  • Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ and Balmain A. . 1995 Cancer Res. 55: 5168–5172.

  • Pandita TK, Hall EJ, Hei TK, Piatyszek MA, Wright WE, Piao CQ, Pandita RK, Willey JC, Geard CR, Kastan MB and Shay JW. . 1996 Oncogene 13: 1423–1430.

  • Pardee AB. . 1989 Science 246: 603–608.

  • Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM and Koff A. . 1994 Genes Dev. 8: 9–22.

  • Ponce-Castaneda MV, Lee MH, Latres E, Polyak S, Lacombe L, Mongomery K, Mathew S, Krauter K, Sheinfeld J, Massague J and Carlos CC. . 1995 Cancer Res. 55: 1211–1214.

  • Serrano M, Hannon GJ and Beach D. . 1993 Nature 366: 704–707.

  • Sgambato A, Han EKH, Zhang YJ, Moon RC, Santella RM and Weinstein IB. . 1995 Carcinogenesis 61: 2193–2198.

  • Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nicholos G, Khaled Z, Telang NT and Narayanan R. . 1995 Proc. Natl. Acad. Sci. USA 92: 12343–12346.

  • Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA and Shay JW. . 1996 J. Invest. Dermatol. 106: 759–765.

  • Tron VA, Tang L, Yong WP and Trotter MJ. . 1996 Am. J. Pathol. 149: 1139–1146.

  • Ueda M, Ouhtit A, Bito T, Nakazawa K, Lubbe J, Ichihashi M, Yamasaki H and Nakazama H. . 1997 Cancer Res. 57: 370–374.

  • Whitaker NJ, Bryan TM, Bonnefin P, Chang AC, Musgrove EA, Braithwaite AW and Reddel RR. . 1995 Oncogene 11: 971–976.

  • Yashima K, Milchgrub S, Gollahon LS, Maitra A, Saboorian MH, Shay JW and Gazdar AF. . 1998 Clin. Cancer Res. 4: 229–234.

  • Yoshimi N, Ino N, Suzui M, Hara A, Kei N, Sato S and Mori H. . 1996 Mol. Carcinog. 16: 1–5.

  • Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, Ide T and Utakoji T. . 1996 Oncogene 13: 433–439.

  • Zhang T, Nanney LB, Luongo C, Lamps L, Heppner KJ, Dubois R and Beauchamp RD. . 1997 Cancer Res. 57: 169–175.

  • Zhou P, Jiang W, Zhang YJ, Khan SH, Schieren I, Santella RM and Weinstein IB. . 1995 Oncogene 11: 571–580.

Download references

Acknowledgements

This work was supported by US Public Health Service Grants R01 CA 51802, P01 CA 48735, P30 CA 43703 and P30 AR 39750.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balasubramanian, S., Kim, KH., Ahmad, N. et al. Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse. Oncogene 18, 1297–1302 (1999). https://doi.org/10.1038/sj.onc.1202417

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202417

Keywords

This article is cited by

Search

Quick links